AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
Saturday September 23rd- Crystal Ballroom CD
Contact Us: Phil McQuain | email@example.com
Technology is not only changing our lives, but also revolutionizing human health. By uniting transformational technology and cutting-edge science, Pfizer is pioneering biopharmaceutical innovations that not only treat difficult diseases – but can cure or prevent them. Every day, Pfizer is working to discover breakthroughs that change patients’ lives and opening new worlds of medical possibilities. We’re applying equal intelligence and passion to help ensure these treatments and therapies are accessible to all. Pfizer is amplifying the power of science and technology, daring more courageously and inquiring more deeply to make what was once unimaginable a reality.
Margaret Brounk | MARGARET.BROUNK@pfizer.com
Keith Stoller | firstname.lastname@example.org
Allison Fertitta | email@example.com
Shreyash Panchal | firstname.lastname@example.org
Aurinia is a biopharmaceutical company focused on developing therapies for patient populations impacted by serious diseases with a high unmet medical need. Aurinia received FDA approval for their first commercially available drug product in January 2021. Please visit www.AuriniaLN.com to learn more.
Sunday, September 24th- Crystal Ballroom CD
Frank Bartram | email@example.com
Jason Plant | firstname.lastname@example.org
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and potentially life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions. For more information, visit the Sanofi website.
Saturday, September 23rd- Crystal Ballroom CD
Mindy Notheis- email@example.com
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Melina Heitkamp | firstname.lastname@example.org
Kalyn Melanophy | email@example.com
GSK is a global biopharma company with a powerful purpose - to unite science, technology, and talent to get ahead of disease together – to positively impact the health of billions of people. We are focused on delivering a new generation of vaccines and medicines, using the science of the immune system, human genetics, and advanced technologies to get ahead of infectious diseases, HIV, immunology, and oncology.
Monique Hunnicutt 757-707-6004
Lauren Shands -202-993-4369
For decades, Janssen has been providing patients and physicians with important therapies to treat rheumatic diseases. We remain focused on complementing our existing portfolio of large-molecule biologics with novel treatments and oral therapeutics in development to provide new options to patients, through a combination of internal research and development, external collaborations, and industry consortia.
Ann Powell | firstname.lastname@example.org | 540-312-3393
We’re pursuing bold advancements in medicine and pushing to close gaps in health care inequality. We’re finding new paths that may lead to the next big breakthroughs, while embracing the diverse perspectives that advance our innovation. But no matter what we’re focused on, we never lose sight of why we’re working—to make life better for people around the world.
Natalia Croly | email@example.com
UCB innovates and delivers solutions that make real improvements for people living with severe diseases. We partner with and listen to patients, caregivers and stakeholders across the healthcare system to identify promising innovations that create valuable health solutions.
Linda Morrell | firstname.lastname@example.org
Stephen Hawes | email@example.com
Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for nearly 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions.
Sarah Knight | firstname.lastname@example.org
ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products.
Marisa Phillips | email@example.com
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products are used to help care for critically and chronically ill patients.
Adreanne Dietrich Adreanne.Dietrich01@Fresenius-Kabi.com
Tom Hartman Thomas.Hartman01@Fresenius-Kabi.com
Novartis is a leading global medicines company, using innovative science and digital technologies to create treatments in areas of great medical need. About 108,000 people of more than 140 nationalities work at Novartis around the world. Find out more at http://www.novartis.us.
Joni Doran | firstname.lastname@example.org
Dave Beard | email@example.com
William Coble | firstname.lastname@example.org
Susan Marino | email@example.com
Website: Novartis Medical
Altus Biologics partners with physicians across multiple specialties to provide comprehensive, in-office infusion and subcutaneous injection services. At Altus Biologics, we are committed to improving access, quality of care and affordability for all patients.
Marty Kelleher | firstname.lastname@example.org
Biocon Biologics is transforming patient outcomes by making life-changing therapies more accessible to the world. Through affordable biosimilars, we are reducing the global healthcare burden, increasing treatment options and driving innovation in biologics, to advance health equity, globally.
Boehringer Ingelheim has 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.
Jonas Brinks | email@example.com
Elizabeth Vivelo | firstname.lastname@example.org
BMS is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience.
Cherie Simon| email@example.com
Kiniksa is a global biopharmaceutical company that finds and delivers novel treatments for patients with significant unmet need. We are focused on building a better future for patients by developing a portfolio of differentiated therapies.
Sharla Kvasnicka | firstname.lastname@example.org
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
Andrew Anguiano | email@example.com
Tracy Gange | firstname.lastname@example.org
Kim Brown | email@example.com
Kevin Lin | firstname.lastname@example.org
ILARIS is FDA Approved to treat 7 autoinflammatory diseases, including Still's Disease (Adult-Onset Still's Disease and SJIA) and Periodic Fever Syndrome (FMF, HIDS/MKD, CAPS (FCAS and MWS), and TRAPS.
Associate Director - Autoinflammatory Disease
Nufactor offers safe, convenient, and reliable infusion solutions for patients receiving IG, antihemophilic factor, and infliximab. Count on us for high-quality therapies and individualized care all in the comfort of your home.
PrismRA® is a blood-based, precision medicine test that helps those with rheumatoid arthritis select the best treatment for their biology sooner.
James Sziksai | email@example.com
To promote the science and practice of Rheumatology, to foster the advancement and education of women in Rheumatology, and advocate access to the highest quality healthcare, and management of patients with Rheumatic disease.
Our mission is to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy. We are focused on achieving the following disease-specific outcomes: reduce time to diagnosis, ensure people wit lupus have an arsenal of safe and effective treatments, and expand direct services and increase access to treatment and care.